A 51-year-old woman with neurofibromatosis type 1 (NF1) was found to have raised blood pressure at a routine follow-up in the Genetic clinic. In view of the recognised association between NF1 and phaeochromocytoma, she was referred to the Blood Pressure Unit in November 1997 for further investigations. Physical examination confirmed the presence of multiple neurofibromas (Figure 1) , and of diffused pigmented spots ('café au lait') ( Figure  2 ), both mainly present on the trunk, arms and legs. No history of palpitations, chest pain or sweating. Blood pressure at presentation, whilst off pharmacological treatment, was 164/108 mm Hg sitting and 163/106 mm Hg standing, with a pulse rate of 74 and 84 b/min, respectively. Fundoscopy did not reveal haemorrhages or papilloedema. Initial investi- gations showed she had normal electrolytes (serum sodium 139 mmol/l and potassium 4.5 mmol/l) and renal function (serum creatinine 79 mol/l), blood glucose 5.3 mmol/l and corrected serum calcium 2.46 mmol/l. However, she had increased urinary excretion (on two consecutive collections) of VMA (188 and 181 mol/24h; nv р36), noradrenaline (1715 and 1442 nmol/24h; nv Ͻ500) and adrenaline (1407 and 1223 nmol/24h; nv Ͻ100). She was started on phenoxybenzamine 10 mg per nocte and the blood pressure fell to 140/85 mm Hg. She then underwent an I-123 MIBG scan of the abdomen. Both the 6 and 24-h images (Figure 3 ), demonstrated two large areas of increased uptake, each in the region of an adrenal gland. Both of these regions had a central photopenic area, consistent with cystic degeneration. Ultrasonography demonstrated bilateral well-defined echogenic large adrenal masses, which had a complex partially cystic and partially There was no evidence of invasion into the liver, spleen, kidneys or IVC. CT scan confirmed these findings. The patient underwent bilateral adrenalectomy. Two large phaeochromocytomas were removed (84 g on the right and 226 g on the left). Microscopy confirmed the clinical diagnosis. Six weeks after surgery blood pressure was 158/89 mm Hg whilst on replacement therapy with hydrocortisone and fludrocortisone and no antihypertensive medication. Urinary and plasma catecholamines were within the normal range.
Neurofibromatosis 1 (NF1), also known as von Recklinghausen's disease, is one of the commonest autosomal dominant disorders in man with an estimated birth incidence of one in 2500 to 3300. 1 The major features are 'café au lait' spots and peripheral neurofibromas. However, the morbidity and mortality caused by NF1 are largely dependent on the numerous complications that can involve any of the body systems (eg, nervous, skeletal, genitourinary, endocrine, cardiovascular, respiratory, gastrointestinal, haematopoietic, skin). 1 The most important medical complication to occur in NF1 is hypertension (about 6% of patients with NF1). 2 It can be essential hypertension or secondary to renal artery stenosis, coarctation of the aorta or phaeochromocytoma. Phaeochromocytomas occur in about one in 1000 hypertensive patients in the general population (though this may be an underestimate). They are a known cause of hypertension amongst patients with NF1 (1-2%), and NF1 is more common amongst patients with phaeochromocytomas (5-25%). However, bilateral phaeochromocytomas are extremely rare. The majority of the phaeochromocytomas in NF1 develop within the adrenal medulla, about 10% being extra-adrenal.
In our patient, biochemical markers showed that the phaeochromocytomas were producing both adrenaline and noradrenaline, which is commonly observed in NF1. 3 Furthermore, the MIBG scanwhich is particularly sensitive at detecting phaeochromocytomas (sensitivity is 90% and false positives are 1-5%)-provided clear-cut diagnostic images and allowed us to localise the masses, to exclude the presence of extra-adrenal uptake and to view degenerative changes within the masses, later confirmed with ultrasound and computerised tomography.
In conclusion, patients with NF1, even with no symptoms, should be screened for phaeochromocytoma.
